Trial Profile
A Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging Study of the Safety, Tolerability and Efficacy of E2007 in Parkinson's Disease Patients With "Wearing Off" Motor Fluctuations and "On" Period Dyskinesias.
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 08 Nov 2021
Price :
$35
*
At a glance
- Drugs Perampanel (Primary)
- Indications Parkinson's disease
- Focus Registrational; Therapeutic Use
- Sponsors Eisai Co Ltd
- 11 Aug 2010 New trial record